- Home
- LPTH vs RCKT Comparison
LPTH vs RCKT Comparison
Compare LPTH & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTH
- RCKT
- Stock Information
- Founded
- LPTH 1985
- RCKT 1999
- Country
- LPTH United States
- RCKT United States
- Employees
- LPTH N/A
- RCKT N/A
- Industry
- LPTH Semiconductors
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- LPTH Technology
- RCKT Health Care
- Exchange
- LPTH Nasdaq
- RCKT Nasdaq
- Market Cap
- LPTH 388.2M
- RCKT 328.6M
- IPO Year
- LPTH 1996
- RCKT N/A
- Fundamental
- Price
- LPTH $7.98
- RCKT $3.77
- Analyst Decision
- LPTH Strong Buy
- RCKT Buy
- Analyst Count
- LPTH 3
- RCKT 13
- Target Price
- LPTH $6.83
- RCKT $12.88
- AVG Volume (30 Days)
- LPTH 2.4M
- RCKT 3.1M
- Earning Date
- LPTH 11-06-2025
- RCKT 11-06-2025
- Dividend Yield
- LPTH N/A
- RCKT N/A
- EPS Growth
- LPTH N/A
- RCKT N/A
- EPS
- LPTH N/A
- RCKT N/A
- Revenue
- LPTH $37,202,630.00
- RCKT N/A
- Revenue This Year
- LPTH $62.13
- RCKT N/A
- Revenue Next Year
- LPTH $22.15
- RCKT $3,592.75
- P/E Ratio
- LPTH N/A
- RCKT N/A
- Revenue Growth
- LPTH 17.26
- RCKT N/A
- 52 Week Low
- LPTH $1.40
- RCKT $2.19
- 52 Week High
- LPTH $10.69
- RCKT $18.25
- Technical
- Relative Strength Index (RSI)
- LPTH 51.50
- RCKT 54.58
- Support Level
- LPTH $7.01
- RCKT $3.63
- Resistance Level
- LPTH $8.92
- RCKT $4.07
- Average True Range (ATR)
- LPTH 1.22
- RCKT 0.29
- MACD
- LPTH -0.25
- RCKT 0.02
- Stochastic Oscillator
- LPTH 27.93
- RCKT 47.19
About LPTH LightPath Technologies Inc.
LightPath Technologies Inc manufactures, distributes, and integrates proprietary optical components and assemblies. It develops optical solutions for traditional optics and communications markets. The company's products include precision molded optics and infrared products, serving markets such as distribution, laser, industrial, instrumentation, telecommunications, and defense. Its products are categorized as infrared components, visible components, assemblies and modules, and engineering services. G5 Infrared's revenue mainly comes from infrared components and assemblies.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.